Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

LBBAP limits hospital readmissions after TAVR
Left bundle branch area pacing is associated with better long-term outcomes than traditional right ventricular pacing when patients require PPMI after TAVR, according to new research in Heart Rhythm.
FDA approves Boston Scientific leads for left bundle branch area pacing
Boston Scientific's INGEVITY+ pacing leads were originally approved by the FDA back in 2019. They can now be used for LBBAP, a new alternative to biventricular pacing.
JACC editor excited by progress during a 'very important moment' for cardiology
Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology, explains some of the key technology and treatment trends he has his eyes on.
FDA approves Biotronik lead, catheter for left bundle branch area pacing
LBBAP is a relatively new alternative to biventricular pacing. The FDA's decision was based largely on data from the BIO-CONDUCT clinical trial.
Surgeons make history, perform world’s first fully robotic heart transplant
The procedure, which lasted roughly two and half hours, was performed on a 16-year-old patient with end-stage heart failure.

Risk score predicts outcomes for heart failure patients undergoing TEER

The new analysis included data from nearly 700 patients who underwent TEER, formerly known as TMVR, over an eight-year period.

July 1, 2021

A closer look at the pandemic's impact on heart attack patients

Patients presenting with an acute myocardial infarction during the start of the COVID-19 pandemic faced delays in care and a higher risk of developing heart failure.

June 29, 2021

Heart failure, heart attack among most common reasons for hospitalization in US

The analysis, published in European Heart Journal Open, also included a look at how COVID-19 may affect these numbers going forward.

June 25, 2021

Statin therapy helps heart failure patients reduce their risk of cancer

The study's authors called for additional research in this area, noting that it may be beneficial to screen all heart failure patients for cancer.

June 24, 2021

FDA announces a new myocarditis warning for COVID-19 vaccines as specialists urge Americans to get vaccinated

In a new statement, the CDC, American Heart Association and several other healthcare organizations highlighted the continued importance of vaccination.

June 24, 2021